XML 19 R3.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Available-for-sale debt and other securities, amortized cost $ 43,754 $ 55,789
Debt securities, fair value 11,554 2
Bank premises and equipment held for sale 24 19
Other short-term investments [1] 21,729 22,082
Total portfolio loans and leases [1] 116,668 117,234
Allowance for loan and lease losses [1] (2,305) (2,322)
Other assets [1] 11,587 12,538
Other liabilities [1] 4,471 4,861
Long-term debt [1] $ 17,096 $ 16,380
Common stock, par value (in dollars per share) $ 2.22 $ 2.22
Common stock, shares authorized (in shares) 2,000,000,000 2,000,000,000
Common stock, outstanding (in shares) 676,268,732 681,124,810
Treasury stock, common (in shares) 247,623,849 242,767,771
Preferred stock, authorized (in shares) 500,000 500,000
Preferred stock, unissued (in shares) 422,000 422,000
Preferred stock, liquidation preference per share (in dollars per share) $ 25,000 $ 25,000
Preferred Class B    
Preferred stock, authorized (in shares) 500,000 500,000
Preferred stock, unissued (in shares) 300,000 300,000
Preferred stock, liquidation preference per share (in dollars per share) $ 1,000 $ 1,000
Residential Mortgage    
Loans held for sale $ 512 $ 334
Loans measured at FV 114 116
Allowance for loan and lease losses (143) (145)
Variable Interest Entity, Primary Beneficiary | Automobile And Solar Loan    
Other short-term investments 50 55
Total portfolio loans and leases 1,131 1,573
Allowance for loan and lease losses (21) (28)
Other assets 8 10
Other liabilities 13 14
Long-term debt $ 1,008 $ 1,409
[1] Includes $50 and $55 of other short-term investments, $1,131 and $1,573 of portfolio loans and leases, $(21) and $(28) of ALLL, $8 and $10 of other assets, $13 and $14 of other liabilities and $1,008 and $1,409 of long-term debt from consolidated VIEs that are included in their respective captions above at September 30, 2024 and December 31, 2023, respectively. For further information, refer to Note 12.